With 251 applications received and only 14 startups selected, this marks a significant milestone and recognition of our mission to revolutionize drug discovery for age-related neurological diseases using AI. This selection highlights the impact of our work in pushing the boundaries of AI-driven healthcare innovation.

As part of this initiative, we join a remarkable group of women-led startups from across Europe and beyond, driving innovation in AI, health tech, sustainability, and more. We are honored to be part of a program that fosters inclusivity and supports female entrepreneurs in deep tech.

A huge thank you to EmpoWomen Programme, Sploro, TechUkraine, Startup Wise Guys, and Business Angels Europe for this incredible opportunity. We are excited to collaborate, grow, and contribute to shaping a more innovative and inclusive future.